Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Taylor JG.

Arch Intern Med. 2002 May 27;162(10):1149-55.

PMID:
12020186
2.

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk.

Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Simpson SH, Taylor JG.

Ann Pharmacother. 1999 Sep;33(9):910-9.

PMID:
10492489
4.

A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).

McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT; SCRIP-HTN Investigators.

Arch Intern Med. 2008 Nov 24;168(21):2355-61. doi: 10.1001/archinte.168.21.2355.

PMID:
19029501
5.
9.

Patient evaluation of a community pharmacy medications management service.

Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P; Community Pharmacy Medicines Management Evaluation Team.

Ann Pharmacother. 2007 Dec;41(12):1962-70. Epub 2007 Oct 30.

PMID:
17971403
10.

Osteoporosis screening and education in community pharmacies using a team approach.

MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR.

Pharmacotherapy. 2005 Mar;25(3):379-86.

PMID:
15843285
11.

The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.

Ali F, Laurin MY, Larivière C, Tremblay D, Cloutier D.

Can J Clin Pharmacol. 2003 Fall;10(3):101-6.

PMID:
14506507
12.

A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.

Fornos JA, Andrés NF, Andrés JC, Guerra MM, Egea B.

Pharm World Sci. 2006 Apr;28(2):65-72. Epub 2006 Jun 22.

PMID:
16791717
13.

Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon JP, Giri M.

J Clin Pharm Ther. 2011 Oct;36(5):602-13. doi: 10.1111/j.1365-2710.2010.01218.x. Epub 2010 Dec 8.

PMID:
21143256
14.
15.

Community pharmacist-provided extended diabetes care.

Doucette WR, Witry MJ, Farris KB, McDonough RP.

Ann Pharmacother. 2009 May;43(5):882-9. doi: 10.1345/aph.1L605. Epub 2009 Apr 28.

PMID:
19401477
16.

A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.

Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP.

Am J Med. 2005 Mar;118(3):276-84.

PMID:
15745726
18.

Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.

Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC.

Ann Intern Med. 2007 May 15;146(10):714-25.

PMID:
17502632
19.
20.

Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education.

Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA, Arnold M, Gauthier S, Avorn J.

J Bone Miner Res. 2007 Nov;22(11):1808-15.

Items per page

Supplemental Content

Write to the Help Desk